Olema Pharmaceuticals, Inc.
Ticker: OLMA
| Insider | Title |
|---|---|
| Andrew Rappaport | Director |
| Biocapital Advisors Gp Llc Paradigm | 10% or greater ownership |
| Biocapital Advisors Lp Paradigm | 10% or greater ownership |
| Biocapital International Fund Ltd. Paradigm | 10% or greater ownership |
| Cynthia M Butitta | Director |
| Cyrus Harmon | Director |
| David C. Myles | CH. DISCOV. NON-CLIN DEV OFF |
| G. Walmsley Graham | Director |
| Gorjan Hrustanovic | Director |
| Gp Holdings Llc Bvf | Director, 10% or greater ownership |
| I Gp Llc Bvf | Director, See Explanation of Responses |
| Ian T Clark | Director |
| Ii Gp Llc Bvf | Director, See Explanation of Responses |
| Inc/il Bvf | Director, 10% or greater ownership |
| J. Scott Garland | Director |
| John B Moriarty | EVP, Ch. Legal Officer Sec. |
| Kinney Horn | Chief Business Officer |
| Mark N Lampert | Director, 10% or greater ownership |
| Naseem Zojwalla | CHIEF MEDICAL OFFICER |
| Partners L P/il Bvf | Director, 10% or greater ownership |
| Partners Os Ltd. Bvf | Director, See Explanation of Responses |
| Peter J. Kushner | CHIEF SCIENTIFIC OFFICER |
| Sandra Horning | Director |
| Sean Bohen | PRESIDENT AND CEO, Director |
| Senai Asefaw | 10% or greater ownership |
| Shane William Charles Kovacs | Ch. Operating Financial Off. |
| Value Fund Ii Lp Biotechnology | Director, See Explanation of Responses |
| Value Fund L P Biotechnology | Director, See Explanation of Responses |
| Value Trading Fund Os Lp Biotechnology | Director, See Explanation of Responses |
| Yi Larson | Director |